Idarubicin improves blast cell clearance during induction therapy in children with AML: results of study AML-BFM 93. AML-BFM Study Group. [electronic resource]
Producer: 20010329Description: 348-54 p. digitalISSN:- 0887-6924
- Antibiotics, Antineoplastic -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Blast Crisis
- Child
- Cytarabine -- administration & dosage
- Daunorubicin -- administration & dosage
- Disease-Free Survival
- Etoposide -- administration & dosage
- Humans
- Idarubicin -- administration & dosage
- Leukemia, Myeloid, Acute -- drug therapy
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.